ATE48413T1 - Aryloxy-n-(aminoalkyl)-1-pyrrolidin und piperidincarboxamide und carbothioamide die antiarrhythmische wirkung hervorrufen. - Google Patents

Aryloxy-n-(aminoalkyl)-1-pyrrolidin und piperidincarboxamide und carbothioamide die antiarrhythmische wirkung hervorrufen.

Info

Publication number
ATE48413T1
ATE48413T1 AT84303995T AT84303995T ATE48413T1 AT E48413 T1 ATE48413 T1 AT E48413T1 AT 84303995 T AT84303995 T AT 84303995T AT 84303995 T AT84303995 T AT 84303995T AT E48413 T1 ATE48413 T1 AT E48413T1
Authority
AT
Austria
Prior art keywords
carbon atoms
lower alkyl
phenyl
aminoalkyl
pyrrolidine
Prior art date
Application number
AT84303995T
Other languages
English (en)
Inventor
Pershottam Prasad Mathur
William Levi Smith
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Application granted granted Critical
Publication of ATE48413T1 publication Critical patent/ATE48413T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT84303995T 1983-12-05 1984-06-13 Aryloxy-n-(aminoalkyl)-1-pyrrolidin und piperidincarboxamide und carbothioamide die antiarrhythmische wirkung hervorrufen. ATE48413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/557,885 US4547514A (en) 1983-12-05 1983-12-05 Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity
EP84303995A EP0147909B1 (de) 1983-12-05 1984-06-13 Aryloxy-N-(Aminoalkyl)-1-pyrrolidin und Piperidincarboxamide und Carbothioamide die antiarrhythmische Wirkung hervorrufen

Publications (1)

Publication Number Publication Date
ATE48413T1 true ATE48413T1 (de) 1989-12-15

Family

ID=24227270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84303995T ATE48413T1 (de) 1983-12-05 1984-06-13 Aryloxy-n-(aminoalkyl)-1-pyrrolidin und piperidincarboxamide und carbothioamide die antiarrhythmische wirkung hervorrufen.

Country Status (15)

Country Link
US (1) US4547514A (de)
EP (1) EP0147909B1 (de)
JP (1) JPS60123466A (de)
KR (1) KR900005133B1 (de)
AT (1) ATE48413T1 (de)
AU (1) AU572747B2 (de)
CA (1) CA1227797A (de)
DE (1) DE3480651D1 (de)
DK (1) DK52784A (de)
ES (4) ES529364A0 (de)
HU (1) HU193719B (de)
IL (1) IL70823A (de)
PH (1) PH20831A (de)
PT (1) PT78090B (de)
ZA (1) ZA84697B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810703A (en) * 1984-10-19 1989-03-07 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4812451A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha.
US4812452A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino) carbonyl and thiocarbonyl)-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US5183902A (en) * 1985-02-28 1993-02-02 A. H. Robins Company, Incorporated Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5151418A (en) * 1985-02-28 1992-09-29 A. H. Robins Company, Incorporated Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
DE3800868A1 (de) * 1988-01-14 1989-07-27 Thomae Gmbh Dr K Mittel zur behandlung von bradycardien und bradyarrhythmien
US5192776A (en) * 1988-03-14 1993-03-09 Hoechst-Roussel Pharmaceuticals Incorporated 1-subsituted-4-pentafluorophenoxypiperidines
US5212184A (en) * 1988-03-14 1993-05-18 Hoechst-Roussel Pharmaceuticals Inc. 1-substituted-4-pentafluorophenoxypiperidines
EP2202223B1 (de) * 2007-10-18 2017-01-25 Takeda Pharmaceutical Company Limited Heterocyclische verbindung als blut-rbp4 senkende agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831862A (en) * 1956-02-27 1958-04-22 Lakeside Lab Inc Ethers of n-alkyl-3-hydroxypiperidine and salts thereof
US3577415A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-substituted phenoxypyrrolidines
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines
FR2315274A1 (fr) * 1975-06-27 1977-01-21 Parcor Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications
US4036957A (en) * 1975-11-18 1977-07-19 A. H. Robins Company, Inc. Phenoxy compounds in combinations to suppress gastric bleeding in aspirin therapy
MX6634E (es) * 1979-01-09 1985-09-12 Robins Co Inc A H Procedimiento para preparar el isomero trans de 3-ariloxi-4-hidroxipirrolidinas

Also Published As

Publication number Publication date
ES555590A0 (es) 1987-07-01
ES8601876A1 (es) 1985-11-16
EP0147909B1 (de) 1989-12-06
ES8802572A1 (es) 1987-07-01
ES544169A0 (es) 1987-01-16
DE3480651D1 (de) 1990-01-11
HUT35648A (en) 1985-07-29
EP0147909A1 (de) 1985-07-10
IL70823A (en) 1987-10-20
PH20831A (en) 1987-04-30
ZA84697B (en) 1984-09-26
JPS60123466A (ja) 1985-07-02
AU572747B2 (en) 1988-05-12
AU2397684A (en) 1985-06-13
ES8802021A1 (es) 1987-01-16
DK52784A (da) 1985-06-06
IL70823A0 (en) 1984-04-30
ES8802571A1 (es) 1987-07-01
US4547514A (en) 1985-10-15
KR850004959A (ko) 1985-08-19
CA1227797A (en) 1987-10-06
PT78090B (en) 1986-04-17
ES529364A0 (es) 1985-11-16
PT78090A (en) 1984-03-01
HU193719B (en) 1987-11-30
DK52784D0 (da) 1984-02-06
ES555591A0 (es) 1987-07-01
KR900005133B1 (ko) 1990-07-20

Similar Documents

Publication Publication Date Title
AU589427B2 (en) Pyridonecarboxylic acid derivatives and process for their preparation
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
ATE120462T1 (de) 1-indolylalkyl-4-(alkoxy-pyrimidinyl)piperazine
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
ATE67995T1 (de) Flavonkarbonsaeure-derivate.
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
AU572747B2 (en) Aryloxy-n-(aminoalkyl)-1-pyrrolide and piperidine carboxamides and carbothiomides having antiarrythmic activity
ES8700857A1 (es) Un procedimiento para la produccion de dihidropiridinas
EP0156331A3 (en) Benzuforan derivatives, processes for preparing the same and antihypertensive agents containing the same
HUT54668A (en) Process for producing acriloyl-piperazine derivatives and pharmaceutical compositions containing them
AU537086B2 (en) 4-amino-2,6-diaryl-tetrahydrothiopyrans
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee